This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (73)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

William B. Hoppenjans, MD; Mark R. Bibler, MD; Robert L. Orme, MD; Alan M. Solinger, MD

Arch Dermatol. 1990;126(8):1048-1050.

Abstract
• We describe the development of prolonged disseminated cutaneous herpes zoster in two patients with acquired immunodeficiency syndrome. Both patients developed hyperkeratotic, verrucous lesions that progressed despite acyclovir therapy. The biopsy specimens were typical of herpes infection. The development of acyclovir-resistant varicella-zoster virus during therapy was suspected clinically in the first patient and documented in vitro in the second patient. The inability to mount an effective cell-mediated immune response contributed to the prolonged course of cutaneous zoster in our patients. The hyperkeratotic nature of the skin lesions may reflect their chronic nature. Treatment with inadequate doses of acyclovir, allowing viral persistence and the selection of resistant strains of virus, may also be implicated. We recommend prolonged high-dose intravenous acyclovir therapy in the initial management of herpes zoster in patients with acquired immunodeficiency syndrome.

(Arch Dermatol. 1990;126:1048-1050)

Author Affiliations
From the Departments of Dermatology (Drs Hoppenjans and Orme) and Medicine (Drs Bibler and Solinger), University of Cincinnati (Ohio) College of Medicine.

Footnotes
Accepted for publication May 9, 1990.

Presented in part at the International Conference on AIDS, Montreal, Quebec, June 5, 1989.

Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Characterization of the DNA polymerase gene of varicella-zoster viruses resistant to acyclovir
Kamiyama et al.
J. Gen. Virol. 2001;82:2761-2765.
ABSTRACT | FULL TEXT  

A Rapid Phenotypic Assay for Detection of Acyclovir-Resistant Varicella-Zoster Virus with Mutations in the Thymidine Kinase Open Reading Frame
Sahli et al.
Antimicrob. Agents Chemother. 2000;44:873-878.
ABSTRACT | FULL TEXT  

Chronic Varicella-zoster Virus Epithelial Keratitis in Patients With Acquired Immunodeficiency Syndrome
Chern et al.
Arch Ophthalmol 1998;116:1011-1017.
ABSTRACT | FULL TEXT  

RESIDENT'S PAGE: PATHOLOGY
ASKIN and WESTRA
Arch Otolaryngol Head Neck Surg 1996;122:194-198.
ABSTRACT  

The Treatment of Acyclovir-Resistant Herpes Zoster With Trifluorothymidine and Interferon Alfa
Rossi et al.
Arch Dermatol 1995;131:24-26.
ABSTRACT  

Asymptomatic Vesicles in a Patient With the Acquired Immunodeficiency Syndrome
Blankenship et al.
Arch Dermatol 1994;130:1193-1194.
ABSTRACT  

Dermatology
Dover and Arndt
JAMA 1991;265:3111-3113.
ABSTRACT  

Varicella-Zoster Virus Disease in Patients With Human Immunodeficiency Virus Infection
Gulick et al.
Arch Dermatol 1990;126:1086-1088.
ABSTRACT